I sat down with Benjamin Jolley, a third-generation pharmacist who recently addressed a crowd of 20,000 about the broken world of PBMs. We dug into the power of that moment, the hidden mechanics of pharmacy monopolies, and what real reform could look like. This one hits where policy meets reality.

Biotech CEO Arun Swaminathan reveals how true pharmaceutical deals are strategic “marriages”—not transactions. Hear how Coya Therapeutics leverages partnerships, builds trust, and aims to transform ALS care. A candid look at negotiation, leadership, and why win-win deals matter in pharma and beyond. Real insights from the C-suite.

Can a small biotech change cancer care—and turn a profit? Paul Romness, CEO of OS Therapies, shares how his five-person team took on one of the deadliest pediatric cancers, went public, and might just shake up the system. From biologics to Wall Street, this one’s got it all. Sponsored by Dae Lee of Buchanan.

Marco Benitez, founder of ROOK, reveals how his company turns chaotic wearable data into clean, actionable insights. From fitness rings to Dexcom integrations, hear how ROOK bridges tech and healthcare, enabling remote monitoring, AI-driven predictions, and more—all without the red tape of FDA regulation. The future of health is wearable. Sponsored by RemediChain.

I sat down with Autumn Kyoko Cushman, co-founder of ShiftRx, staffing leader, to hear how she and her team clawed their way back from the edge. From bounced credit cards to nationwide scale—this one’s raw, real, and a must-listen for anyone building in pharmacy.

The host and his brothers (Mike Koelzer, along with brothers Pete Koelzer⁠, ⁠Tom Koelzer⁠, ⁠and Tim Koelzer⁠) return to where it all started—the family drugstore. From early paper routes to late nights after close mopping the store, they reflect on the work ethic, values, and business lessons they learned from their dad. It’s a heartfelt, behind-the-scenes look at how one small pharmacy helped shape four lives—and four very different careers.

I sat down again with Kris Rhea to unpack how pharmacies are silently losing money—just by buying wrong. We talk wholesaler games, misunderstood contracts, and the AI tool trying to fix it all. If you’ve ever felt like your drug spend makes no sense, this one’s for you.

I sat down with Joey Dizenhouse, CEO of SlateRx, to talk about redefining pharmacy benefits—minus the gimmicks. We dug into transparency, real fiduciary alignment, and how SlateRx is tackling PBM dysfunction head-on. If you're tired of smoke and mirrors in the benefits space, this episode is for you. Sponsored by WaypointRx.

Michelle Woosley blends pharmacy know-how with M&A savvy. She shares how independent pharmacy owners can build value, avoid costly mistakes, and attract serious buyers—including private equity. Thinking about selling your pharmacy someday? Don’t miss this one. Michelle’s advice could mean the difference between walking away… or leaving money on the table.